VYNE Therapeutics Statistics
Total Valuation
VYNE has a market cap or net worth of $30.95 million. The enterprise value is -$54.88 million.
| Market Cap | 30.95M |
| Enterprise Value | -54.88M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VYNE has 14.53 million shares outstanding. The number of shares has increased by 1,208.17% in one year.
| Shares Outstanding | 14.53M |
| Shares Change (YoY) | +1,208.17% |
| Shares Change (QoQ) | +314.49% |
| Owned by Insiders (%) | 8.45% |
| Owned by Institutions (%) | 57.02% |
| Float | 9.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 73.16 |
| Forward PS | 86.68 |
| PB Ratio | 0.37 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.02, with a Debt / Equity ratio of 0.00.
| Current Ratio | 13.02 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.90% and return on invested capital (ROIC) is -36.82%.
| Return on Equity (ROE) | -57.90% |
| Return on Assets (ROA) | -49.80% |
| Return on Capital (ROIC) | -36.82% |
| Revenue Per Employee | $42,300 |
| Profits Per Employee | -$2.91M |
| Employee Count | 10 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.88% in the last 52 weeks. The beta is 1.46, so VYNE's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -52.88% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 2.55 |
| Relative Strength Index (RSI) | 51.08 |
| Average Volume (20 Days) | 60,370 |
Short Selling Information
The latest short interest is 55,857, so 0.38% of the outstanding shares have been sold short.
| Short Interest | 55,857 |
| Short Previous Month | 62,680 |
| Short % of Shares Out | 0.38% |
| Short % of Float | 0.57% |
| Short Ratio (days to cover) | 0.79 |
Income Statement
In the last 12 months, VYNE had revenue of $423,000 and -$29.08 million in losses. Loss per share was -$1.21.
| Revenue | 423,000 |
| Gross Profit | 423,000 |
| Operating Income | -30.76M |
| Pretax Income | -29.08M |
| Net Income | -29.08M |
| EBITDA | -29.08M |
| EBIT | -29.08M |
| Loss Per Share | -$1.21 |
Balance Sheet
The company has $86.00 million in cash and $180,000 in debt, giving a net cash position of $85.82 million or $5.91 per share.
| Cash & Cash Equivalents | 86.00M |
| Total Debt | 180,000 |
| Net Cash | 85.82M |
| Net Cash Per Share | $5.91 |
| Equity (Book Value) | 83.37M |
| Book Value Per Share | 5.74 |
| Working Capital | 83.29M |
Cash Flow
| Operating Cash Flow | -27.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | -27.85M |
| FCF Per Share | -$0.65 |
Margins
Gross margin is 100.00%, with operating and profit margins of -7,272.81% and -6,874.47%.
| Gross Margin | 100.00% |
| Operating Margin | -7,272.81% |
| Pretax Margin | -6,874.47% |
| Profit Margin | -6,874.47% |
| EBITDA Margin | -6,874.47% |
| EBIT Margin | -6,874.47% |
| FCF Margin | -6,582.74% |
Dividends & Yields
VYNE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,208.17% |
| Shareholder Yield | -1,208.17% |
| Earnings Yield | -93.97% |
| FCF Yield | -89.98% |
Analyst Forecast
The average price target for VYNE is $5.75, which is 169.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.75 |
| Price Target Difference | 169.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 167.61% |
| EPS Growth Forecast (5Y) | -44.01% |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:18.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:18 |
Scores
VYNE has an Altman Z-Score of -8.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.37 |
| Piotroski F-Score | 2 |